News and Resources
News and resources
'Vaccine bonds' offer Japanese savers an ethical investment
Vaccine bonds will offer Japanese investors a fixed rate of return plus an opportunity to see their money used to help immunise children in the world's poorest countries.
With new 'Vaccine Bonds' Japanese Investors will have the opportunity to save more children’s lives in the poorest countries of the world
New "Vaccine Bonds" expected to be offered in Japan by Daiwa Securities Group next year aim to accelerate immunisation of children in the world's poorest countries against deadly diseases. These new Vaccine Bonds would be the second initiative of its kind in Japan to use the capital markets to raise funds for a specific development purpose. [Englis...
Japanese investors welcome the launch of IFFIm’s debut 'vaccine bonds'
Japanese investors welcomed the launch of the debut offering in the Japanese market of the International Finance Facility for Immunisation Company
'Vaccine bonds' offered in Japan will help save children’s lives in the developing world
A "vaccine bond" expected to be offered in Japan next month aims to accelerate efforts to immunise children in the world’s poorest countries against deadly diseases, the first initiative of its kind in Japan to use the capital markets to raise funds for a specific development purpose.
'Vaccine Bonds' to speed up access to life saving vaccines in the poorest countries around the world
Daiwa Securities Group, the International Finance Facility for Immunisation Company, the GAVI Alliance, and the World Bank, announce IFFIm’s expected inaugural issuance of notes under its Global Debt Issuance Programme targeting mainly Japanese retail investors.
First year results: IFFIm provides US$ 1 billion to prevent disease
Nearly US$ 1 billion is being injected into life-saving vaccines and health services in developing countries as a result of the bond issuance by the International Finance Facility for Immunisation (IFFIm) one year ago this month.
Bond investors speed up access to life saving vaccines
The GAVI Alliance announced today it will distribute almost US$1 billion in funds in 2007, raised by the International Facility for Immunisation (IFFIm) on capital markets to help poor nations prevent life-threatening diseases and strengthen their health systems.
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.